Re: Carrat et al. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.
作者信息
Samuel Alexander
机构信息
, Nice, France.
出版信息
Eur J Epidemiol. 2022 Oct;37(10):1083-1084. doi: 10.1007/s10654-022-00925-x. Epub 2022 Oct 26.
Abstract
摘要
相似文献
1
Re: Carrat et al. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.关于：卡拉特等人。2019冠状病毒病在法国早期传播的证据：基于人群的“康斯坦斯”队列研究结果。
Eur J Epidemiol. 2022 Oct;37(10):1083-1084. doi: 10.1007/s10654-022-00925-x. Epub 2022 Oct 26.
2
Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.法国早期 SARS-CoV-2 循环的证据：基于人群的“CONSTANCES”队列研究结果。
Eur J Epidemiol. 2021 Feb;36(2):219-222. doi: 10.1007/s10654-020-00716-2. Epub 2021 Feb 6.
3
Protocol for a prospective quasi-experimental study on SARS-CoV-2 transmission during outdoor sports events in France: the COVID-ESO project.一项关于 SARS-CoV-2 在法国户外运动期间传播的前瞻性准实验研究方案：COVID-ESO 项目。
BMJ Open. 2022 Jun 16;12(6):e055927. doi: 10.1136/bmjopen-2021-055927.
4
Impact of the COVID-19 pandemic on preterm birth and stillbirth: a nationwide, population-based retrospective cohort study.2019年冠状病毒病大流行对早产和死产的影响：一项基于全国人口的回顾性队列研究
Am J Obstet Gynecol. 2021 Sep;225(3):347-348. doi: 10.1016/j.ajog.2021.05.015. Epub 2021 May 19.
5
Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022.2022 年 2 月，法国一名免疫抑制患者持续性感染 SARS-CoV-2 Alpha 变异株。
Emerg Infect Dis. 2022 Jul;28(7):1512-1515. doi: 10.3201/eid2807.220467. Epub 2022 May 6.
6
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.2021 年 1 月至 3 月法国对 SARS-CoV-2 谱系 20I/501Y.V1（B.1.1.7，202012/01 关注变体）的扩散和可能扩大的早期评估。
Euro Surveill. 2021 Mar;26(9). doi: 10.2807/1560-7917.ES.2021.26.9.2100133.
7
Spread of SARS-CoV-2 Variants on Réunion Island, France, 2021.法国留尼汪岛 2021 年 SARS-CoV-2 变异株的传播。
Emerg Infect Dis. 2022 Apr;28(4):895-898. doi: 10.3201/eid2804.212243.
8
Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France.法国郊区人群中 SARS-CoV-2 血清流行率、症状谱和血清中和抗体情况
Viruses. 2021 Jun 4;13(6):1076. doi: 10.3390/v13061076.
9
Attitudes about COVID-19 Lockdown among General Population, France, March 2020.2020 年 3 月法国普通人群对 COVID-19 封锁的态度。
Emerg Infect Dis. 2021 Jan;27(1):301-3. doi: 10.3201/eid2701.201377. Epub 2020 Nov 12.
10
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France.家庭内接触 SARS-CoV-2 与无血清转化的细胞免疫反应相关，法国。
Emerg Infect Dis. 2021 Jan;27(1):113-21. doi: 10.3201/eid2701.203611. Epub 2020 Dec 1.
引用本文的文献
1
Emergency department CT examinations demonstrate no evidence of early viral circulation at the start of the COVID-19 pandemic-a multicentre epidemiological study.急诊科CT检查显示，在新冠疫情初期没有早期病毒传播的迹象——一项多中心流行病学研究。
Insights Imaging. 2024 Jan 17;15(1):14. doi: 10.1186/s13244-023-01590-8.
本文引用的文献
1
Cross-reactive CD4 T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.交叉反应性 CD4 T 细胞增强了感染和接种 SARS-CoV-2 后的免疫反应。
Science. 2021 Oct 8;374(6564):eabh1823. doi: 10.1126/science.abh1823.
2
Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equi.新兴大环内酯类（多药）耐药马红球菌的pRErm46赋予的抗菌耐药谱
J Clin Microbiol. 2021 Sep 20;59(10):e0114921. doi: 10.1128/JCM.01149-21. Epub 2021 Jul 28.
3
Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study.利用年龄分层的住院和血清学数据监测 SARS-CoV-2 感染人群的比例：一项建模研究。
Lancet Public Health. 2021 Jun;6(6):e408-e415. doi: 10.1016/S2468-2667(21)00064-5. Epub 2021 Apr 8.
4
Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.法国早期 SARS-CoV-2 循环的证据：基于人群的“CONSTANCES”队列研究结果。
Eur J Epidemiol. 2021 Feb;36(2):219-222. doi: 10.1007/s10654-020-00716-2. Epub 2021 Feb 6.
5
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors.法国 O 型血献血者中，中和 SARS-CoV-2 的抗体流行率较低。
Antiviral Res. 2020 Sep;181:104880. doi: 10.1016/j.antiviral.2020.104880. Epub 2020 Jul 15.
Zotero 插件